A purification process for vaccines produced via a measles vector platform will soon lead to a more flexible, reproductive and economic process contributing to the faster development and production of vaccines.
mRNA vaccines gained widespread notoriety for their revolutionary power in combating the Corona pandemic. But behind the scenes, a silent hero called pseudouridine plays a crucial role in maximising their efficacy and safety. Pseudouridine, a modified RNA building block, has the remarkable ability to increase RNA stability and fine-tune immune responses, making it a valued component in the world of mRNA therapeutics. However, with the increasing demand for these breakthrough vaccines, the question arises: how can we produce pseudouridine sustainably without compromising efficiency or environmental impact?
Living fossils allow us a glimpse into a time long past, for they have changed little or not at all over millions of years. The platypus or the horseshoe crabs are well-known representatives from the world of animals; among plants, horsetail, ginkgo or the box tree are considered such living fossils. But the world of microorganisms can also come up with living fossils: the so-called archaea are a special group of microorganisms, which are characterised by a special composition of the cytoplasmic membrane and sometimes also through specific cell envelope that is not found in bacteria or eukaryotic organisms…
A balanced diet is important, we learn that from an early age. The more natural the ingredients and the shorter the supply chains, the better for our health and for the environment. Nevertheless, a trend is currently developing in biotechnology towards food ingredients fresh from the laboratory. Probiotics from intestinal bacteria, flavourings from yeast fungi or artificial meat from animal cell cultures – all these examples are the subject of daily research in industrial biotechnology.
A Europe-wide project named “Piezo4Spine” sets the high goal of developing a novel therapy against spinal cord injuries (SCI). Based on the latest findings in materials science, regenerative medicine and nanotechnology, research is being conducted on a 3D-theramesh equipped with bioactive nanocarriers that delivers therapeutic agents to the site of the lesion through electrical stimulation. These bioactive ingredients activate the neuronal regeneration processes after an SCI has occurred. If successful, this technology could be useful in the future for pathologies such as Alzheimer’s or Parkinson’s disease, among others.
The MOOC “The new plastics economy: circular business models and sustainability”, realized within the Horizon 2020 BIO-PLASTICS EUROPE project
One of the greatest difficulties in combating viral infectious diseases is the excellent adaptability of viruses. Especially with of SARS-CoV-2 new variants are quickly and constantly forming, bringing different properties with them. That’s why it’s important that in the future it will be crucial to predict more quickly and precisely how dangerous a virus can become.
You have a complex chemical process that is no longer competitive? Countries with low salary levels are beginning to gain market share for cost reasons? Let acib solve your problems by discovering new and cost-efficient routes for chemo-enzymatic synthesis of your target compound(s).
acib developed a biotechnological based technology for the recycling of waste pharmaceutical blisters. Aluminium and plastic can be recovered by applying the concept of green chemistry.
Wastewater-based detection of emerging diseases has been proven to be a powerful tool during the COVID-19 pandemic. Now it’s high time to switch from a time-consuming manual and decentralized process to a fully-automated multiple-disease detection and surveillance system.
